MDxHealth S.A.

NASDAQ:MDXH

Medical - Diagnostics & Research

Healthcare
$0.60 -4.45%

-$0.03 today

Market cap
$57.59M
Beta
0.38
P/E (TTM)
-1.0
EPS (TTM)
-$0.58
52W Low $0.40High $5.33

Volume 0.65M

Average 4.27M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$10.42M

FY 2025 · Annual

Investing Cash Flow

-$20.06M

FY 2025 · Annual

Financing Cash Flow

$12.70M

FY 2025 · Annual

-71.5% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(26.84M)(37.9M)(27.33M)(24.72M)(14.41M)
Depreciation & Amortization3.04M4.91M6.86M8.04M9.21M
Deferred Income Tax00000
Stock-Based Compensation1.22M867K665K1.73M2.21M
Change in Working Capital360K(1.57M)(2.12M)(3.86M)939K
Accounts Receivables(1.38M)(5.12M)(1.68M)(3.23M)2.32M
Inventory413K(416K)(452K)(1.09M)(1.93M)
Accounts Payables0000550K
Other Working Capital1.33M3.97M20K458K0
Other Non-Cash Items(325K)(429K)421K286K(8.37M)
Operating Cash Flow(22.55M)(34.12M)(21.5M)(18.53M)(10.42M)
Capital Expenditures(896K)(4.16M)(5.02M)(2.16M)(1.16M)
Acquisitions (Net)0(25M)000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities11K(1.25M)(1.18M)(448K)(18.9M)
Investing Cash Flow(885K)(29.04M)(3.93M)(1.64M)(20.06M)
Debt Repayment(1.06M)22.13M(3.27M)11.59M21.6M
Common Stock Issued68.57M039.6M40.74M0
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.01M)(1.41M)(4.05M)(7.73M)(8.91M)
Financing Cash Flow66.5M20.72M32.28M44.6M12.7M
Effect of Forex Changes(520K)(555K)25K(14K)16K
Net Change in Cash42.55M(43M)6.88M24.42M(17.77M)
Free Cash Flow(23.44M)(38.28M)(26.52M)(20.69M)(11.57M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$14.4M
+ D&A$9.2M
+ Stock-Based Comp$2.2M
+ Deferred Tax$0
+ Working Capital$939.0K
- Other Non-Cash-$8.4M
= Operating Cash Flow-$10.4M
- Capex-$1.2M
= Free Cash Flow-$11.6M

Analysis

FY2025 free cash flow is -$11.6M. FCF conversion is 80.3% of net income. Operating cash flow was -$10.4M, with capex of -$1.2M. The largest bridge item is D&A at $9.2M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13D/ASC 13D/A filingOct 15, 2026
144Notice of proposed sale of securitiesSep 17, 2026
6-K6-K filingSep 3, 2026
SC 13G/ASC 13G/A filingAug 17, 2026
4Statement of changes in beneficial ownershipAug 17, 2026

Does MDXH generate free cash flow?

MDxHealth S.A. (MDXH) generated -$11.57M of free cash flow in fiscal 2025.

How much operating cash flow does MDXH produce?

Operating cash flow was -$10.42M, before capital expenditures of $1.16M.